Ocuphire Pharma
Pharmaceutical ManufacturingMichigan, United States11-50 Employees
Ocuphire Pharma, Inc. and Opus Genetics have combined (Nasdaq: IRD). --> Please follow the Opus Genetics page for future updates. <-- As a combined company, we are committed to building an innovative, efficient and sustainable clinical-stage ophthalmic biopharmaceutical company leading the development of transformative gene therapies for the treatment of inherited retinal diseases (IRDs) and therapies to treat patients with other retinal and refractive disorders.